We did not find this journal in the SCIE, SSCI, AHCI, ESCI, Scopus or JCR 2024 lists. That does not make it unreliable, but check its indexing, peer review and fees carefully.
How to spot predatory journals →Our experts shortlist up to 5 journals that match your manuscript, indexing requirement and target quartile, and handle the submission.
Journal Selection & Submission →Indexing of Drug Repurposing for Emerging Infectious Diseases and Cancer
| List | Status |
|---|---|
| Science Citation Index Expanded (SCIE) | Not found |
| Social Sciences Citation Index (SSCI) | Not found |
| Arts & Humanities Citation Index (AHCI) | Not found |
| Emerging Sources Citation Index (ESCI) | Not found |
| Scopus | Not found |
| Journal Citation Reports 2024 | Not found |
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. ScholarsColab does not show impact factors or quartiles, which are licensed; see how JCR and CiteScore quartiles work.
What Drug Repurposing for Emerging Infectious Diseases and Cancer publishes: real papers
Papers by ScholarsColab mentors in Drug Repurposing for Emerging Infectious Diseases and Cancer
- Targeting the Ubiquitin Machinery for Cancer Therapeutics
Ekta Tripathi
Reviewer comments and rejection reasons for Drug Repurposing for Emerging Infectious Diseases and Cancer
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Planning to submit here? A Manuscript Audit by a PhD reviewer in your area checks your paper for the issues reviewers raise most often.
Get a Manuscript Audit →Preparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
Journals similar to Drug Repurposing for Emerging Infectious Diseases and Cancer
Journals where our mentors published the closest work to the papers above:
- Anti-Cancer Agents in Medicinal ChemistrySCIEScopusJCR 20244 mentor papers
- Bioorganic ChemistrySCIEScopusJCR 202414 mentor papers
- Journal of Medicinal ChemistrySCIEScopusJCR 20242 mentor papers
- Clinical Cancer ResearchSCIEScopusJCR 20242 mentor papers
- Research Journal of Pharmacy and TechnologyScopus11 mentor papers
- Current Research in Pharmacology and Drug DiscoveryScopus1 mentor paper
Find the right journal for your paper
Is Drug Repurposing for Emerging Infectious Diseases and Cancer right for your paper? Compare journals
Paste your title, keywords or abstract. We match it against 28,582 journal papers published by PhD researchers on ScholarsColab and show where the closest work appeared, with each journal’s indexing (SCIE, SSCI, AHCI, ESCI, Scopus, JCR 2024).
How it works: no AI or language model is used. Your words are matched against the titles of real published papers by our mentors; journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; “not found in our indexing lists” does not prove a journal is unindexed. Always check a journal’s scope and current indexing before submitting.
Frequently asked questions
Is Drug Repurposing for Emerging Infectious Diseases and Cancer indexed in Scopus?
Drug Repurposing for Emerging Infectious Diseases and Cancer was not found in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Drug Repurposing for Emerging Infectious Diseases and Cancer an SCIE journal?
Drug Repurposing for Emerging Infectious Diseases and Cancer was not found in SCIE or the other Web of Science indexes, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Drug Repurposing for Emerging Infectious Diseases and Cancer in Journal Citation Reports (JCR)?
Drug Repurposing for Emerging Infectious Diseases and Cancer was not found in the JCR 2024 list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Have ScholarsColab mentors published in Drug Repurposing for Emerging Infectious Diseases and Cancer?
Yes. 1 paper by 1 mentor was published in Drug Repurposing for Emerging Infectious Diseases and Cancer in 2023, with 1 citations in total.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.